Gil Melmed, MD, from Cedars-Sinai Medical Center in Los Angeles, California, talks about what constitutes a good quality report following a colonoscopy on a patient with inflammatory bowel disease.
Russell Cohen, MD, director of the Inflammatory Bowel Disease Center at UChicago Medicine, discusses using biologic agents to treat patients with Crohn disease and ulcerative colitis.
Hans Herfarth, MD, professor of medicine at the University of North Carolina, discusses the primary indication for the use of methotrexate — in the treatment of patients with Crohn disease who are
Marla Dubinsky, MD, division chief of pediatric gastroenterology and nutrition and codirector of the Susan and Leonard Feinstein IBD Clinical Center at the Icahn School of Medicine at Mt.
Raymond Cross, MD, director of the Inflammatory Bowel Disease program at the University of Maryland School of Medicine, discussed the positioning and uses of 5-ASAs and corticosteroids in the treat
Michele Rubin, APN, of UChicago Medicine, discusses the importance of finding the right drug for each patient as part of the move toward personalized medicine.